| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $187,128,701 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31AI191958 | Mapping the mutational landscape of CD4bs broadly neutralizing HIV antibodies | 001 | 1 | NIH | 4/21/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31AI191958 | Mapping the mutational landscape of CD4bs broadly neutralizing HIV antibodies | 000 | 1 | NIH | 4/21/2026 | $42,960 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R03DE035541 | Impact of Bariatric Surgery on the Risk of Adverse Oral Health Outcomes | 000 | 1 | NIH | 4/27/2026 | $323,366 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K01DK147576 | Skeletal Muscle Mitochondrial Efficiency in GLP-1RA-induced Weight Loss | 000 | 1 | NIH | 6/19/2026 | $143,550 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG097580 | Real-world evidence to clarify risk-benefit of antihypertensive intensification vs. de-escalation and blood pressure thresholds to minimize harms and maximize brain and heart health in older adults | 000 | 1 | NIH | 7/17/2026 | $660,505 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | S10OD040117 | LUMICKS C-Trap Edge 350 | 000 | 1 | NIH | 6/11/2026 | $1,079,965 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | UH3CA287109 | Population Health Management Approaches to Increase Lung Cancer Screening in Community Health Centers | 001 | 3 | NIH | 6/17/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | UH3CA287109 | Population Health Management Approaches to Increase Lung Cancer Screening in Community Health Centers | 000 | 3 | NIH | 6/11/2026 | $1,154,997 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01NS149744 | The roles of microtubule-associated serine/threonine kinase-1 in regulating neuronal development | 000 | 1 | NIH | 7/14/2026 | $601,829 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21NS145030 | Pathogenic mechanisms of expanded ZFHX3 in SCA4 cerebellar organoids | 000 | 1 | NIH | 6/18/2026 | $423,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI193502 | Tregs: The force is strong in this one | 000 | 1 | NIH | 6/18/2026 | $3,072,554 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21EY038741 | High-Throughput Computational Pipeline for Rapid Development of Photocaged Peptide Tools | 000 | 1 | NIH | 7/20/2026 | $616,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL180922 | The Pyruvate-Lactate Metabolic Axis in Heart Failure and Recovery | 000 | 1 | NIH | 6/19/2026 | $635,681 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA300362 | Effects of combined FAK inhibition with MAPK blockade in brain metastases from cutaneous melanoma | 001 | 1 | NIH | 3/31/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21MH140161 | An Integrated Circuit Model for Temporal Coding in Lateral and Medial Entorhinal Cortex | 000 | 1 | NIH | 3/6/2026 | $423,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA300362 | Effects of combined FAK inhibition with MAPK blockade in brain metastases from cutaneous melanoma | 000 | 1 | NIH | 3/27/2026 | $634,900 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI187812 | Deciphering the Interplay of Depleting Anti-PD-1 Antibodies and Autoimmune Environments in Type-1 Diabetes: Towards Better Utility of Therapeutic Antibody | 000 | 1 | NIH | 2/19/2026 | $756,078 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AI189586 | Development of HTS for discovery of IL-25 inhibitors | 000 | 1 | NIH | 2/6/2026 | $423,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AI190576 | Delving into peptide specificity of NK inhibitory receptors | 000 | 1 | NIH | 3/27/2026 | $423,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HD117924 | Social Isolation Re-Organizes Neural Dynamics Governing Mating | 000 | 1 | NIH | 6/19/2026 | $657,829 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30HD118749 | Image-Based Modeling of Pediatric Charcot-Marie-Tooth Disease Relative to Neuromuscular Development and Treatment | 002 | 1 | NIH | 4/1/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30HD118749 | Image-Based Modeling of Pediatric Charcot-Marie-Tooth Disease Relative to Neuromuscular Development and Treatment | 001 | 1 | NIH | 2/4/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30HD118749 | Image-Based Modeling of Pediatric Charcot-Marie-Tooth Disease Relative to Neuromuscular Development and Treatment | 000 | 1 | NIH | 2/4/2026 | $54,538 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | RF1MH123489 | Prediction of suicide death using EHR and polygenic risk scores | 000 | 7 | NIH | 6/19/2026 | $2,956,888 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K99HD122051 | Co-Developing the My Ultimate Stroke Toolkit (MUST): A User-Centered Post-Discharge Education and Training Program for Stroke Survivors and Caregivers | 000 | 1 | NIH | 7/14/2026 | $133,812 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA304572 | Fibrin-laden tumor stroma as a novel immunomodulatory factor in pancreatic ductal adenocarcinoma | 000 | 1 | NIH | 7/20/2026 | $639,573 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AI196901 | Dissecting T Cell Developmental Defects in Down Syndrome | 000 | 1 | NIH | 1/30/2026 | $454,482 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM162610 | Investigating the biological functions, biosynthesis, and dynamic regulations of RNA chemical modifications | 000 | 1 | NIH | 3/3/2026 | $423,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM162026 | Development and Application of Nicotinic Acetylcholine Receptor Targeted Peptides for Biomedical Research | 000 | 1 | NIH | 3/2/2026 | $500,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AI197490 | Cholesterol Metabolism in Regulatory T cell Function | 000 | 1 | NIH | 1/30/2026 | $423,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K99CA307604 | Harnessing Androgen-Driven Immune Modulation to Enhance Immunotherapy for Endocrine Cancers | 000 | 1 | NIH | 4/29/2026 | $126,933 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00DA059957 | Cross-region neural mechanisms that support conditioned taste aversion | 000 | 3 | NIH | 1/21/2026 | $249,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL179352 | Elucidating the molecular mechanisms of smoking-induced endothelial dysfunction associated with ALDH2*2 | 000 | 1 | NIH | 5/4/2026 | $470,606 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R25DK145420 | Haumana 'O Pasifika Homeostasis Program | 000 | 1 | NIH | 5/5/2026 | $108,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA176839 | Targeting Oncogenic NRAS, BRAF plus PI3'-Kinase Signaling for Melanoma Therapy | 000 | 9 | NIH | 4/17/2026 | $385,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30AI191743 | Directed evolution of a nascent immune function | 002 | 1 | NIH | 4/2/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30AI191743 | Directed evolution of a nascent immune function | 001 | 1 | NIH | 4/2/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30AI191743 | Directed evolution of a nascent immune function | 000 | 1 | NIH | 3/27/2026 | $40,547 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21MH140335 | Elucidating the Role of the Hippocampus in Motor Memory using Temporal Interference Stimulation | 000 | 1 | NIH | 3/10/2026 | $402,802 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K01HG014200 | Addressing ethical challenges in whole genome sequencing implementation through human-centered design and ethnography | 001 | 1 | NIH | 5/14/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K01HG014200 | Addressing ethical challenges in whole genome sequencing implementation through human-centered design and ethnography | 000 | 1 | NIH | 5/12/2026 | $658,836 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM161383 | Molecular and Metabolic Adaptations of Intracellular Parasitism | 000 | 1 | NIH | 2/27/2026 | $423,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R25GM161925 | PULSE (Program Understanding and Learning through Strategic Evaluation) | 001 | 1 | NIH | 6/10/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31HL182196 | SNAP23 is a Novel Regulator of Autophagy in Cardiac Myocytes | 000 | 1 | NIH | 6/30/2026 | $40,799 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R25GM161925 | PULSE (Program Understanding and Learning through Strategic Evaluation) | 000 | 1 | NIH | 3/11/2026 | $105,987 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31ES038448 | Air pollution mixtures and pregnancy: assessing exposure, estimating risk, and predicting susceptibility with machine learning | 001 | 1 | NIH | 5/6/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31ES038448 | Air pollution mixtures and pregnancy: assessing exposure, estimating risk, and predicting susceptibility with machine learning | 000 | 1 | NIH | 4/8/2026 | $44,201 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00GM155552 | The regulatory landscape of segmentally duplicated genes: Implications for human evolution and disease | 000 | 3 | NIH | 1/9/2026 | $248,965 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23DK143313 | Implementing Social Drivers of Health Screening and Interventions to Reduce Health Disparities in Chronic Liver Disease | 000 | 1 | NIH | 3/19/2026 | $210,189 |
|
